In Figure 6e, compared to PBS control, CD31 immunohistochemical staining with tumor model mice was conducted on the 25th day after injecting L1 (10 mg/kg), and they exhibited an obviously decreased tumor angiogenesis rate, which showed L1 could inhibit tumor growth. This evidence concerns the gene PECAM1 and neoplasm.